Misdiagnosis of a medical condition is costly for the patient, the physician and the insurance company, and can lead to outcomes as severe as death. How bad is the problem of misdiagnosis in healthcare settings, and what can be done to minimize this problem? Hear more from Dr. Joseph Britto of Isabel Healthcare.
Misdiagnoses: Costs, Prevalence & Solutions
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Misdiagnosis of a medical condition is costly for the patient, the physician and the insurance company, and can lead to outcomes as severe as death. How bad is the problem of misdiagnosis in healthcare settings, and what can be done to minimize this problem? Hear more from Dr. Joseph Britto of Isabel Healthcare.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
MinuteCE®
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
1.00 credits
<p>Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time</p>
MinuteCE®
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
0.50 credits
<p>What do we know now that could have changed the history of CETP inhibition?: genetics and biology </p>
MinuteCE®
CETP inhibition: Lessons from two decades of clinical trials
0.50 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">CETP inhibition: Lessons from two decades of clinical trials</span></p>
NeuroFrontiers
mIDH Gliomas Explained: Characteristics and Management Strategies
<p>mIDH Gliomas Explained: Characteristics and Management Strategies</p>
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
<p>From Diagnosis to Treatment: Challenges in Glioblastoma Care</p>
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
<p>Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data</p>
Clinician's Roundtable
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
<p>Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder</p>
Clinician's Roundtable
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
<p>Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?